CTOs on the Move

Menlo Therapeutics

www.menlotherapeutics.com

 
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Solomon Wang
 Director of Information Technology Profile

Funding

Menlo Therapeutics raised $50M on 07/18/2017

Similar Companies

Strand Life Sciences

Strand Life Sciences was founded in 2000 by four computer scientists with one objective: to apply the algorithms of computer coding to the life sciences. We leveraged this unique convergence of technology and biology expertise to develop a strong portfolio of products internationally that support research and diagnosis and treatment of disease. Today, our products are used in more than 2,000 scientific laboratories and 100 hospitals around the world.

Condensed Curriculum International Inc

Condensed Curriculum International Inc is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MMH Partners

MMH Partners, LP is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Programable Devices Inc

Programable Devices Inc is a Danvers, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cosmetic Industries

Cosmetic Industries is a Fontana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.